These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24500020)

  • 1. Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study.
    Hertle E; van Greevenbroek MM; Arts IC; van der Kallen CJ; Geijselaers SL; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Thromb Haemost; 2014 Jun; 111(6):1102-11. PubMed ID: 24500020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study.
    Wijnands JM; Boonen A; Dagnelie PC; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Schalkwijk CG; Feskens EJ; Stehouwer CD; van der Linden S; Arts IC
    Rheumatology (Oxford); 2014 Nov; 53(11):2053-62. PubMed ID: 24917566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study.
    Wlazlo N; van Greevenbroek MM; Ferreira I; Jansen EJ; Feskens EJ; van der Kallen CJ; Schalkwijk CG; Bravenboer B; Stehouwer CD
    Metabolism; 2012 Dec; 61(12):1787-96. PubMed ID: 22762725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Cigarette Smoking With Subclinical Inflammation and Atherosclerosis: ELSA-Brasil (The Brazilian Longitudinal Study of Adult Health).
    Kianoush S; Yakoob MY; Al-Rifai M; DeFilippis AP; Bittencourt MS; Duncan BB; Bensenor IM; Bhatnagar A; Lotufo PA; Blaha MJ
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study).
    van Greevenbroek MM; Jacobs M; van der Kallen CJ; Blaak EE; Jansen EH; Schalkwijk CG; Feskens EJ; Stehouwer CD
    Int J Cardiol; 2012 Jan; 154(2):158-62. PubMed ID: 20926148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. The CODAM study.
    Hertle E; Arts IC; van der Kallen CJ; Feskens EJ; Schalkwijk CG; Stehouwer CD; van Greevenbroek MM
    Thromb Haemost; 2016 Jan; 115(2):446-57. PubMed ID: 26446431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical Pathway of Complement Activation: Longitudinal Associations of C1q and C1-INH With Cardiovascular Outcomes: The CODAM Study (Cohort on Diabetes and Atherosclerosis Maastricht)-Brief Report.
    Hertle E; Arts ICW; van der Kallen CJH; Feskens EJM; Schalkwijk CG; Stehouwer CDA; van Greevenbroek MMJ
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1242-1244. PubMed ID: 29567681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima-Media Thickness: The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study.
    Hertle E; Arts IC; van der Kallen CJ; Feskens EJ; Schalkwijk CG; Hoffmann-Petersen IT; Thiel S; Stehouwer CD; van Greevenbroek MM
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1278-85. PubMed ID: 27055907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors.
    Nilsson B; Hamad OA; Ahlström H; Kullberg J; Johansson L; Lindhagen L; Haenni A; Ekdahl KN; Lind L
    Eur J Clin Invest; 2014 Jun; 44(6):587-96. PubMed ID: 24754458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis.
    McEvoy JW; Nasir K; DeFilippis AP; Lima JA; Bluemke DA; Hundley WG; Barr RG; Budoff MJ; Szklo M; Navas-Acien A; Polak JF; Blumenthal RS; Post WS; Blaha MJ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1002-10. PubMed ID: 25745060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement proteins and arterial calcification in middle aged women: Cross-sectional effect of cardiovascular fat. The SWAN Cardiovascular Fat Ancillary Study.
    Nagaraj N; Matthews KA; Shields KJ; Barinas-Mitchell E; Budoff MJ; El Khoudary SR
    Atherosclerosis; 2015 Dec; 243(2):533-9. PubMed ID: 26523990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome.
    Stokowska A; Olsson S; Holmegaard L; Jood K; Blomstrand C; Jern C; Pekna M
    Cerebrovasc Dis; 2011; 32(2):114-22. PubMed ID: 21709409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BclI glucocorticoid receptor polymorphism in relation to cardiovascular variables: the Hoorn and CODAM studies.
    van Moorsel D; van Greevenbroek MM; Schaper NC; Henry RM; Geelen CC; van Rossum EF; Nijpels G; 't Hart LM; Schalkwijk CG; van der Kallen CJ; Sauerwein HP; Dekker JM; Stehouwer CD; Havekes B
    Eur J Endocrinol; 2015 Oct; 173(4):455-64. PubMed ID: 26139210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study.
    Raiko JR; Oikonen M; Wendelin-Saarenhovi M; Siitonen N; Kähönen M; Lehtimäki T; Viikari J; Jula A; Loo BM; Huupponen R; Saarikoski L; Juonala M; Raitakari OT
    Atherosclerosis; 2012 Sep; 224(1):208-12. PubMed ID: 22840426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.
    Oikonen M; Wendelin-Saarenhovi M; Lyytikäinen LP; Siitonen N; Loo BM; Jula A; Seppälä I; Saarikoski L; Lehtimäki T; Hutri-Kähönen N; Juonala M; Kähönen M; Huupponen R; Viikari JS; Raitakari OT
    Atherosclerosis; 2012 Aug; 223(2):497-503. PubMed ID: 22749515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early life origins of low-grade inflammation and atherosclerosis risk in children and adolescents.
    Labayen I; Ortega FB; Sjöström M; Ruiz JR
    J Pediatr; 2009 Nov; 155(5):673-7. PubMed ID: 19595364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cigarette smoking on ceruloplasmin and C3 complement: risk of cardiovascular disease (atherosclerosis).
    Tungtrongchitr R; Pongpaew P; Phonrat B; Supawan V; Chanjanakitskul S; Vudhivai N; Schelp FP
    Asian Pac J Allergy Immunol; 2002 Mar; 20(1):23-8. PubMed ID: 12125914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of subjects at risk for vascular remodelling - results from the Swiss population-based study SAPALDIA.
    Dratva J; Caviezel S; Schaffner E; Zemp E; de Groot E; Schmidt-Trucksäss A; Bettschart R; Saleh L; Turk A; Gaspoz JM; Carballo D; Kuenzli N; Probst-Hensch N
    Swiss Med Wkly; 2014; 144():w14052. PubMed ID: 25356963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.